ABX advanced biochemical compounds GmbH   Report issue

For profit Phase 3
Founded: Radeberg Germany (2008)

Organization Overview

First Clinical Trial
2019
NCT04102553
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ABX advanced biochemical compounds GmbH